Sign in
CompletedPhase 2

Cold-stored Platelet Early Intervention in TBI

Key facts

Who runs it
Jason Sperry
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
100 people enrolled
Started
21 Mar 2022
Ended
13 May 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cold Stored Platelets
  • Standard Care
Record updated
11 May 2025

Who can take part

Age
18 years to 89 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Patients with traumatic brain injury, defined by presence of potential progressive intracranial injury on CT scan, at significant risk for urgent neurosurgical procedure as determined by neurosurgical evaluation, who meet at least one of the following:
  • History or indication of pre-injury antiplatelet agent use
  • Need for platelet transfusion per standard practice

Who cannot take part

  • Currently on therapeutic anticoagulant in addition to aspirin and/or clopidogrel (e.g. warfarin, direct-acting oral anticoagulants)
  • Platelet transfusion contraindications per care team (for example, recent vascular stent, embolic stroke, intracranial and/or vascular lesions)
  • Age > 89 or < 18 years of age
  • Wearing NO CriSP opt out bracelet
  • Hypotension in Emergency Department (SBP< 90 mmHg)
  • Penetrating injury
  • Prisoner
  • Pregnancy
  • Going to operating room for non-neurosurgical intervention in first 60 minutes
  • Objection to study voiced by participant or family member in Emergency Department

Where in United States

  • University of PittsburghPittsburgh, United States

About the trial

What the trial wants to find out

The Cold Stored Platelet Early Intervention in Traumatic Brain Injury (CriSP-TBI) trial is a proposed 3 year, open label, single center, randomized trial designed to determine the feasibility, efficacy, and safety of urgent release cold stored platelets (CSP) in patients with TBI requiring platelet transfusion. Patients will be randomized to receive either standard care or early infusion of urgent release cold stored platelets (CSP). The proposed pilot study will enroll at the University of Pittsburgh and will enroll approximately 100 patients. The primary outcome for the pilot trial is feasibility, with principal secondary clinical outcome of 6-month Extended Glasgow Outcome Scale (GOS-E).

The 2 groups in the trial

  • Cold-stored Platelet (CSP)Treatment being tested

    early infusion of up to 2 units of urgent release cold stored platelets (CSP)

    Treatment: Cold Stored Platelets

  • Standard careExisting treatment, for comparison

    standard care therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cold Stored Platelet Early Intervention in Traumatic Brain Injury Trial
Record updated
11 May 2025